— Know what they know.
Not Investment Advice

RGEN NASDAQ

Repligen Corporation
1W: -4.2% 1M: +5.1% 3M: +28.4% YTD: +10.6% 1Y: +24.6% 3Y: +12.9% 5Y: -43.8%
$181.70
+4.47 (+2.52%)
 
Weekly Expected Move ±6.0%
$160 $171 $182 $193 $203
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 62 · $10.3B mcap · 53M float · 2.07% daily turnover · Short 70% of daily vol

📊 Key Metrics

TTM
$785M
Revenue
+16.5% YoY
$42M
Net Income
+400.4% YoY
$111M
Free Cash Flow
+4.6% YoY
53.1%
Gross Margin
5.8%
Op. Margin
2.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE2.0%
ROA1.4%
ROIC2.6%

Valuation

P/E245.5
P/B4.9
EV/EBITDA62.5

Leverage

Debt/Equity0.33
Current Ratio9.05
Interest Cov.3.5x

Quality Scores

Piotroski F8/9
Altman Z6.54
Beneish M-2.66

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms